Skin Treatment - Kenya

  • Kenya
  • In Kenya, the revenue in the Skin Treatment market market in 2024 amounts to US$21.18m.
  • This market is projected to experience an annual growth rate of 6.73% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, reaching US$4,184.00m in 2024.
  • In terms of per person revenues, in Kenya generates US$0.38 in 2024.
  • Kenya's skin treatment OTC pharmaceutical market is witnessing a surge in demand for natural and organic products.

Key regions: Australia, Brazil, Canada, China, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Skin Treatment market in Kenya is experiencing significant growth and development, driven by various factors such as changing customer preferences, emerging trends, and local special circumstances. Customer preferences in the Skin Treatment market in Kenya are shifting towards natural and organic products. Consumers are becoming more conscious about the ingredients used in skincare products and are opting for products that are free from harmful chemicals. This preference for natural and organic skincare products is in line with the global trend, where consumers are increasingly seeking products that are environmentally friendly and have minimal impact on their health.In addition to the preference for natural and organic products, customers in Kenya are also showing a growing interest in skincare products that cater to specific skin concerns. This includes products that target issues such as acne, hyperpigmentation, and aging. As consumers become more educated about skincare, they are seeking out products that address their individual needs and provide targeted solutions.One of the key trends in the Skin Treatment market in Kenya is the rise of local and indigenous skincare brands. These brands are gaining popularity among consumers who are looking for products that are made with locally sourced ingredients and cater to the specific needs of the Kenyan population. This trend is driven by a desire to support local businesses and promote the use of traditional ingredients and remedies.Another trend in the market is the increasing popularity of online shopping for skincare products. With the rise of e-commerce platforms and the convenience of online shopping, more consumers in Kenya are turning to online retailers to purchase their skincare products. This trend is also driven by the COVID-19 pandemic, which has led to an increase in online shopping across various industries.In terms of local special circumstances, Kenya has a diverse population with different skin types and needs. This diversity presents an opportunity for skincare brands to develop products that cater to the specific needs of different ethnicities and skin tones. Brands that can effectively address the unique skincare concerns of the Kenyan population are likely to gain a competitive advantage in the market.Underlying macroeconomic factors also play a role in the development of the Skin Treatment market in Kenya. The country has been experiencing steady economic growth, which has led to an increase in disposable income and consumer spending. As consumers have more purchasing power, they are able to afford higher-quality skincare products and are willing to invest in their skincare routines.In conclusion, the Skin Treatment market in Kenya is witnessing growth and development driven by changing customer preferences, emerging trends, and local special circumstances. The preference for natural and organic products, the demand for targeted skincare solutions, the rise of local brands, and the popularity of online shopping are all contributing to the market's expansion. Additionally, the diverse population and economic growth in Kenya provide opportunities for skincare brands to cater to the specific needs of consumers and capitalize on the increasing disposable income.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)